BSBenedict Stanberry

Benedict Stanberry

*This is an algorithmically generated author record based on publicly available information.

Benedict Stanberry has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rotational Percutaneous Mechanical Thrombectomy for Acute and Subacute Limb Ischaemia: A Systematic Review and Proportional Meta-Analysis

    by Benedict Stanberry, Koen Deloose, Yann Gouëffic, Gilles Goyault, Giacomo Isernia, Ralph Jackson, Nils Kucher, Michael Lichtenberg, James McCaslin, Bruno Migliara, et al.

    Objective: Rotational percutaneous mechanical thrombectomy with adjunctive angioplasty, stenting or limited thrombolysis (rPMT+) has become commonplace in the treatment of acute and subacute limb ischaemia (SLI). This systematic review and proportional meta-analysis synthesises the available evidence on its safety and efficacy. Data Sources: MEDLINE, Embase and the Cochrane Library. Review Methods: We searched for studies (≥10 patients) published since January 1, 2012 (PROSPERO protocol CRD420251015846). Risk of bias was assessed using RoBANS 2. Proportional meta-analysis maximised representative sample sizes by incorporating both single-arm and comparative studies. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) evidence profiles were developed for each outcome of interest. Results: Twenty-four studies – 7 comparative and 17 single arm – containing 2954 procedures (2697 rPMT+, 257 controls) met eligibility criteria. There were no randomised controlled trials. The pooled technical success (TS) rate for rPMT+ was 98% (95% confidence interval [CI]: 97%–100%, p < .001). Amputation-free survival (AFS) was 96% (95% CI: 93%–98%, p < .001). Twelve-month primary patency (PP) was 68% (95% CI: 55%–79%, p < .001). The pooled rate of freedom from clinically-driven target lesion revascularisation was 85% (95% CI: 80%–90%, p < .001). No significant differences existed between acute, subacute and mixed subgroups. Procedure-related mortality was 0.5% (11 deaths in 2086 procedures from 17 studies) with most deaths occurring after adjunctive catheter-directed thrombolysis. Major adverse events occurred in 4% of procedures (95% CI: 1%–8%, p < .001) and distal embolisation in 8% (95% CI: 5%–11%, p < .001). rPMT+ reduced length of stay by 1.7 days versus alternatives (95% CI: 3.3%–0.1 days, p < .05). All outcomes demonstrated heterogeneity; GRADE assessment rated evidence certainty as low to very low. Conclusion: The evidence available from 24 real-world observational studies of 2954 procedures supports the use of rPMT+ in acute limb ischaemia and SLI – delivering an overall pooled TS rate of 98% and AFS rate of 96% with no significant differences between acute, subacute and mixed subgroups. rPMT+ is associated with shorter hospital stays than either surgery or thrombolysis. Clinical Impact: This systematic review and proportional meta-analysis synthesises 24 single-arm and comparative non-randomised studies encompassing nearly 3000 procedures to provide a comprehensive assessment of the safety and efficacy of rotational percutaneous mechanical thrombectomy in patients with acute and subacute lower limb ischaemia. It demonstrates that, when used for initial revascularisation prior to adjunctive angioplasty, stenting or limited thrombolysis, this endovascular approach delivers clinically valuable rates of technical success and amputation-free survival with notably high rates of freedom from clinically-driven target lesion revascularisation, acceptable primary patency, low procedural risk and significantly shorter hospital stays.

  • Open Access

    Rotational Percutaneous Mechanical Thrombectomy for Acute and Subacute Limb Ischaemia: a Systematic Review and Proportional Meta-analysis

    by Benedict Stanberry, Koen Deloose, Yann Gouëffic, Gilles Goyault, Giacomo Isernia, Ralph Jackson, Nils Kucher, Michael Lichtenberg, James McCaslin, Bruno Migliara, et al.

    Objective: Rotational percutaneous mechanical thrombectomy with adjunctive angioplasty, stenting or limited thrombolysis (rPMT+) has become commonplace in the treatment of acute and subacute limb ischaemia. This systematic review and proportional meta-analysis synthesises the available evidence on its safety and efficacy. Data Sources: MEDLINE, Embase and the Cochrane Library. ≥ Review Methods: We searched for studies (≥10 patients) published since 1 January 2012 (PROSPERO protocol CRD420251015846). Risk of bias was assessed using RoBANS 2. Proportional meta-analysis maximised representative sample sizes by incorporating both single-arm and comparative studies. GRADE evidence profiles were developed for each outcome of interest. Results: Twenty-four studies – seven comparative and 17 single arm – containing 2,954 procedures (2,697 rPMT+, 257 controls) met eligibility criteria. There were no randomised controlled trials. The pooled technical success (TS) rate for rPMT+ was 98% (95% CI: 97-100%, p p p p p p p <0.05). All outcomes demonstrated heterogeneity. GRADE assessment rated evidence certainty as low to very low. Conclusion: rPMT+ delivers consistently high TS and AFS rates, promising 12-month fCDTLR, acceptable PP, low procedural risk and shorter hospital stays than comparators. The consistency of favourable outcomes supports its use as a safe and effective treatment in appropriately selected ALI and SLI patients. WHAT THIS PAPER ADDS: This systematic review and proportional meta-analysis synthesises 24 single-arm and comparative non randomised studies encompassing nearly 3,000 procedures to provide a comprehensive assessment of the safety and efficacy of rotational percutaneous mechanical thrombectomy in patients with acute and subacute lower limb ischaemia. It demonstrates that, when used for initial revascularisation prior to adjunctive angioplasty, stenting or limited thrombolysis, this endovascular approach delivers consistently high rates of technical success and amputation-free survival with notably high rates of freedom from clinically-driven target lesion revascularisation, acceptable primary patency, low procedural risk and significantly shorter hospital stays.

  • Open Access

    Changing gloves during caesarean birth: impact on maternity service budgets and capacity

    by B. Stanberry, L. Jordan, A. Pullyblank, J. Hargreaves

  • Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations

    by Benedict Stanberry, Nikki Webber-Jones

    Background This study supports a value-based approach to prostate cancer (PCa) treatment by systematically reviewing economic evaluations that compare the cost and cost-effectiveness of low-dose-rate brachytherapy (LDR-BT) with that of other treatment options for localised and locally advanced PCa. Methods Studies published between 2008 and 2023 were searched for in MEDLINE, EMBASE and Tufts Medical Center’s Cost-Effectiveness Analysis (CEA) Registry (Prospero protocol CRD42023-442027). Two reviewers independently screened the title and abstracts based on agreed inclusion and exclusion criteria, followed by full-text screening. The Drummond checklist was used to critically appraise the quality of the included studies. Results After screening 453 records, 36 were sought for retrieval and 14 eligible studies included. Of them, 11 compared treatments for low- and/or favourable intermediate-risk PCa, 2 compared options for unfavourable intermediate- and/or high-risk disease and 1 analysed treatments for both risk groups. Considerable heterogeneity was seen in the populations, perspectives, time horizons, costs and outcomes data used. If the oncological outcomes of standard treatment approaches are considered equivalent, LDR-BT was the most cost-effective type of radiation therapy (RT) in 9 (75%) of 12 studies, was more cost-effective than radical prostatectomy (RP) in 6 (67%) of 9 studies and, depending on the time horizon, was more cost-effective than active surveillance (AS) in 3 (60%) of 5 studies. LDR-BT was more cost-effective than high-dose-rate brachytherapy (HDR-BT) in all 4 (100%) of the studies that made this comparison and, overall, LDR-BT was the least costly of all active treatment options in 7 (50%) of the 14 studies. Conclusion The available health economic evidence suggests that LDR-BT has significant cost advantages and an important role to play in the delivery of value-based PCa care. In the future these advantages could be challenged if radiotherapy favours ultrahypofractionated strategies such as stereotactic body radiation therapy (SBRT) and reduced fractionation in HDR-BT.


  • Open Access

    Preventing pressure ulcers in emergency departments: four simple and effective nurse-led changes

    by Benedict Stanberry, Nina Lahti, Caroline Kevin, Jenny Delin

    Patients can develop pressure ulcers within a few hours of entering an emergency department (ED). However, despite the critical role of EDs in reducing the incidence of pressure ulcers, few have protocols in place for prevention. This article describes the prevention emergency project (PEP), a quality improvement project undertaken in


  • Open Access

    Using the MEAT VBP Framework to analyse and understand the value of surgical gloves: an explanatory case study

    by Benedict Stanberry, Gerhard Bothma, Katie Harrison

    Background: Value-based healthcare is being extensively piloted, scaled and implemented by healthcare providers and systems around the world. However, the ability of the healthcare supply chain function to strategically contribute to the improvement of value has been held back by a lack of practical tools for turning value-based procurement from concept into action. Two recently developed conceptual models – the American CQO Movement and the European MEAT VBP Framework – have been developed to support the implementation of value-based procurement in healthcare. We demonstrate how the latter of these models can be adapted and applied pragmatically to generate insights into the value of a specific medical device, technology or consumable.Methods: We undertook an explanatory, qualitative, single-case study focused on a specific consumable – surgical gloves – that provide a critical example of a type of medical device usually procured in high volumes but at risk of commoditisation due to a widespread lack of understanding of their value. Since the global Covid-19 pandemic prevented fieldwork, structured interviews were conducted via Zoom and corroborated by a literature review.Results: We identified ten cost criteria and eight outcome criteria with which the value of surgical gloves can be analysed and understood. For each of these criteria we propose definitions and value impact metrics that decision-makers can use during a procurement exercise to describe, quantify and compare glove value.Conclusion: The MEAT VBP Framework provides a highly practical and adaptable means of imposing both structure and rigour on a value analysis process and of qualitatively describing the potential value impact of surgical gloves for patients, professionals, providers and health systems.